Development of new antivirals. [ 2012 - 2013 ]

Research Grant

Researchers: Prof Paul Hertzog (Principal investigator) ,  Mr Mark Sullivan

Brief description Despite recent advances in therapeutic options, chronic viral infections, including infection with hepatitis C virus and hepatitis B virus, continue to be a significant cause of morbidity and mortality in Australia and affecting hundreds of millions of people worldwide. This R&D program aims to develop a cheaper drug formulation that is easier to deliver and more stable for transport to remote areas.

Funding Amount $AUD 433,465.49

Funding Scheme NHMRC Development Grants

Notes Development Grant